Insurer and provider groups railed against the CMS' proposal to use more patient-encounter data for Medicare Advantage plans' risk scores in 2019, but supported its suggestion to account for patients' mental health and substance abuse disorders.Original Article
You may also like
Gone in a Puff of Smoke? FDA’s Proposed Rule on...
FDA Appears to Be Granting Zombie Rare Pediatric...
HPM’s Larry Houck Presenting at WCF Opioid and...
Get Up To Speed on Medicare Inflation Rebates: HPM...
Into the Ashtray: FDA’s Previous Proposal to Ban...
Small Change: FDA’s Final Predetermined Change...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.